Synthetic gene circuits for the detection, elimination and prevention of disease

被引:97
作者
Sedlmayer, Ferdinand [1 ]
Aubel, Dominique [2 ]
Fussenegger, Martin [1 ,3 ]
机构
[1] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland
[2] Univ Claude Bernard Lyon 1, IUTA Dept Genie Biol, Lyon, France
[3] Univ Basel, Fac Sci, Basel, Switzerland
来源
NATURE BIOMEDICAL ENGINEERING | 2018年 / 2卷 / 06期
基金
欧洲研究理事会;
关键词
CONTROLLED TRANSGENE EXPRESSION; DESIGNER CELLS; MAMMALIAN-CELLS; T-CELLS; TRANSCRIPTIONAL ACTIVATION; ENGINEERED BACTERIA; AUTOMATED DESIGN; BIOLOGY; RNA; DELIVERY;
D O I
10.1038/s41551-018-0215-0
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
In living organisms, naturally evolved sensors that constantly monitor and process environmental cues trigger corrective actions that enable the organisms to cope with changing conditions. Such natural processes have inspired biologists to construct synthetic living sensors and signalling pathways, by repurposing naturally occurring proteins and by designing molecular building blocks de novo, for customized diagnostics and therapeutics. In particular, designer cells that employ user-defined synthetic gene circuits to survey disease biomarkers and to autonomously re-adjust unbalanced pathological states can coordinate the production of therapeutics, with controlled timing and dosage. Furthermore, tailored genetic networks operating in bacterial or human cells have led to cancer remission in experimental animal models, owing to the network's unprecedented specificity. Other applications of designer cells in infectious, metabolic and autoimmune diseases are also being explored. In this Review, we describe the biomedical applications of synthetic gene circuits in major disease areas, and discuss how the first genetically engineered devices developed on the basis of synthetic-biology principles made the leap from the laboratory to the clinic.
引用
收藏
页码:399 / 415
页数:17
相关论文
共 165 条
  • [1] Synthetic biology and therapeutic strategies for the degenerating brain Synthetic biology approaches can transform classical cell and gene therapies, to provide new cures for neurodegenerative diseases
    Agustin-Pavon, Carmen
    Isalan, Mark
    [J]. BIOESSAYS, 2014, 36 (10) : 979 - 990
  • [2] Amir Y, 2014, NAT NANOTECHNOL, V9, P353, DOI [10.1038/NNANO.2014.58, 10.1038/nnano.2014.58]
  • [3] Engineering Modular Viral Scaffolds for Targeted Bacterial Population Editing
    Ando, Hiroki
    Lemire, Sebastien
    Pires, Diana P.
    Lu, Timothy K.
    [J]. CELL SYSTEMS, 2015, 1 (03) : 187 - 196
  • [4] Synthetic biology devices and circuits for RNA-based 'smart vaccines': a propositional review
    Andries, Oliwia
    Kitada, Tasuku
    Bodner, Katie
    Sanders, Niek N.
    Weiss, Ron
    [J]. EXPERT REVIEW OF VACCINES, 2015, 14 (02) : 313 - 331
  • [5] A race to bring CRISPR to the clinic
    不详
    [J]. EBIOMEDICINE, 2017, 19 : 1 - 1
  • [6] A Synthetic Multifunctional Mammalian pH Sensor and CO2 Transgene-Control Device
    Auslaender, David
    Auslaender, Simon
    Charpin-El Hamri, Ghislaine
    Sedlmayer, Ferdinand
    Mueller, Marius
    Frey, Olivier
    Hierlemann, Andreas
    Stelling, Joerg
    Fussenegger, Martin
    [J]. MOLECULAR CELL, 2014, 55 (03) : 397 - 408
  • [7] A designer cell-based histamine-specific human allergy profiler
    Auslaender, David
    Eggerschwiler, Benjamin
    Kemmer, Christian
    Geering, Barbara
    Auslaender, Simon
    Fussenegger, Martin
    [J]. NATURE COMMUNICATIONS, 2014, 5
  • [8] Ausländer S, 2014, NAT METHODS, V11, P1154, DOI [10.1038/NMETH.3136, 10.1038/nmeth.3136]
  • [9] From gene switches to mammalian designer cells: present and future prospects
    Auslaender, Simon
    Fussenegger, Martin
    [J]. TRENDS IN BIOTECHNOLOGY, 2013, 31 (03) : 155 - 168
  • [10] Programmable single-cell mammalian biocomputers
    Auslaender, Simon
    Auslaender, David
    Mueller, Marius
    Wieland, Markus
    Fussenegger, Martin
    [J]. NATURE, 2012, 487 (7405) : 123 - +